ESCEO: REMS PUBLICATION WINS “THE PAPER OF THE MONTH”

 

“Longitudinal changes of the femoral bone mineral density from first to third trimester of pregnancy: bone health assessment by means of non‑ionizing REMS technology”

Ruben Ramirez Zegarra1 Valentina Degennaro1 Maria Luisa Brandi 2 Greta Cagninelli 1 Sergio Casciaro 3,4 Gabriella Celora1 Francesco Conversano 3,4 Fiorella A. Lombardi 3 Paola Pisani 3 Tullio Ghi 1

1 Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Italy

2 Fondazione Italiana per la Ricerca sulle Malattie dell’Osso (F.I.R.M.O.), Florence, Italy

3 Institute of Clinical Physiology, National Research Council, Lecce, Italy

4 Echolight Spa, Lecce, Italy

Highlight:

REMS technology allowed to monitor bone health throughout pregnancy, from the first to the third gestational trimester. REMS revealed a significant reduction in bone mass, of more than 2%, at the femoral site even from the first trimester of gestation.

This was demonstrated by a study conducted at the University Hospital of Parma, by longitudinally assessing the changes in the bone health status of a cohort of 65 pregnant women from the eleventh week of gestation. The patients underwent two femoral REMS scans, at first and third trimester of the pregnancy, respectively.

The study highlights that REMS ultrasound technology is an important tool for assessing and monitoring BMD, even during pregnancy, and opens new perspectives for the evaluation of the impact of drug treatment on maternal bone mass.

REMS Performance

REMS Performance

The very recent study titled “Proposed practice parameters for the performance of radiofrequency Echographic multispectrometry (REMS) evaluations” and published on the Bone Joint Open by international key Opinion Leaders from USA and UK showed that REMS are becoming a...

mehr lesen
REMS vs DXA

REMS vs DXA

Does Radiofrequency Echographic Multi-Spectrometry (REMS) perform similarly to Dual-energy X-ray Absorptiometry (DXA) in terms of Trabecular Bone Score (TBS) and FRAX? Débora Meira Ramos Amorim, Eliane Naomi Sakane,  Sergio Setsuo Maeda, Marise Lazaretti-Castro....

mehr lesen
HTA Study in USA

HTA Study in USA

“Cost-effectiveness of radiofrequency echographic multi-spectrometry  for the diagnosis of osteoporosis in the United States":   Jean-Yves Reginster 1, Stuart L. Silverman 2 , Majed Alokail 1, Nasser Al-Daghri 1, Mickael Hiligsmann 3, 1 Bioochemistry Department,...

mehr lesen

    Kontaktieren Sie uns

    Mehr Informationen oder eine Demo buchen.

    Position*

    [select* medical_specialty id:medical_specialty class:selezione first_as_label "Fachrichtung*" "Allergologie/Immunologie" "Anästhesie und Intensivmedizin "Kardiologie" "Klinische Physiologie" "Dermatologie" "Endokrinologie" "Epidemiologie" "Gastroenterologie" "Allgemeinmedizin" "Geriatrie" "Gynäkologie" "Gesundheit & Fitness" "Innere Medizin" "Neurologie" "Neurochirurg" "Nuklearmedizin" "Pflegekraft" "Ernährungsberater" "Onkologie" "Kieferorthopädie" "Orthopädie" "Osteopathie" "HNO" "Pädiatrie" "Apotheke" "Physiatrie" "Physiotherapie" "Podologie" "Psychiatrie" "Radiologie" "Radiologietechnologe" "Wissenschaftler" "Rehabilitation" "Rheumatologie" "Sportmedizin" "Chirurg" "Traumatologie" "Urologie" "Allgemeinmediziner" "Akademiker]

    *Pflichtfelder

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.